Good afternoon :)
Place Order
Add to Watchlist

Krishna Institute of Medical Sciences Ltd

KIMS

Krishna Institute of Medical Sciences Ltd

KIMS
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹23,590 cr, stock is ranked 314
Low RiskStock is 1.69x as volatile as Nifty
610.001.25% (+7.55)
610.001.25% (+7.55)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹23,590 cr, stock is ranked 314
Low RiskStock is 1.69x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹23,590 cr, stock is ranked 314
Low RiskStock is 1.69x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
71.2011.27—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.116.510.52%

Forecast & Ratings

Detailed Forecast 
85%
Analysts have suggested that investors can buy this stock

from 13 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.

Investor Presentation

View older 

Nov 9, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 22.14%, vs industry avg of 10.02%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 2.52% to 4.06%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue516.39569.93700.94923.871,128.731,340.111,680.602,238.382,511.202,721.99
Raw Materialssubtract125.82138.50165.28216.93257.22282.64367.500.000.002,001.94
Power & Fuel Costsubtract13.6814.1816.6520.6424.2924.3125.8343.6949.03
Employee Costsubtract80.7297.98121.71163.03198.05220.21261.91346.44422.37
Selling & Administrative Expensessubtract52.1951.3723.3041.1838.7029.6839.1376.4677.90
Operating & Other expensessubtract130.53147.49266.23391.61354.90397.38434.831,120.341,301.14
Depreciation/Amortizationsubtract35.5035.1340.0756.1270.6169.5472.67129.26146.55161.68
Interest & Other Itemssubtract37.0432.5088.1649.4044.4337.3321.8737.2854.5766.63
Taxes & Other Itemssubtract14.2920.2326.9132.6121.3477.80124.17148.58149.50160.41
EPS0.150.18-0.31-0.310.641.062.848.417.758.28
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 24PDF
May 19PDF
Feb 10PDF
Nov 10PDF
FY 2023

Annual report

PDF

Investor Presentation

May 18PDF
Feb 9PDF
Nov 11PDF
Aug 10PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 7PDF
FY 2025

Annual Report Pending

Investor Presentation

Nov 9PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Krishna Institute of Medical Sciences Ltd76.0611.27—
Apollo Hospitals Enterprise Ltd109.2713.410.23%
Max Healthcare Institute Ltd90.0511.330.15%
Fortis Healthcare Ltd83.105.820.15%

Price Comparison

Compare KIMS with any stock or ETF
Compare KIMS with any stock or ETF
KIMS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.99%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding38.82%25.77%6.53%15.85%13.03%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep13.15%14.25%15.27%16.73%17.84%15.85%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Krishna Institute of Medical Sciences Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
SBI Small Cap Fund - Growth - Direct Plan

Growth
2.8467%2.03%0.41%18/63 (+9)
HDFC Small Cap Fund - Growth - Direct Plan

Growth
2.6847%1.86%0.47%12/92 (+41)
Axis Small Cap Fund - Growth - Direct Plan

Growth
2.4866%2.45%0.47%6/136 (+31)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Krishna Institute of Medical Sciences Ltd

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

KIMS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Spotlight
KIMS Hospitals' gains as Q2 PAT climbs 9% YoY; ARPOB at Rs 38,263

Gross revenue stood at Rs 782 crore during the quarter, registering a growth of 19.4% on YoY basis. Profit before tax grew 11.47% YoY to Rs 99.1 crore in the quarter ended 30 September 2024. Consolidated EBITDA increased by 23.8% YoY to Rs 223 crore and EBITDA margin rose to 28.7% in Q2 FY25 as against 27.6% in Q2 FY24. Krishna Institute's average revenue per occupied bed (ARPOB) rose by 22.9% YoY to Rs 38,263. Average revenue per patient (ARPP) grew by 9.7% YoY to Rs 1,40,316. The company conducted 4.73 lakhs OPD consults in Q2 FY25, which increased by 12.2% on YoY basis. Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: 'The second quarter has been an extremely busy and productive one on multiple fronts for us. Our unit in Nashik went live this quarter and we are happy to say that we have started our first hospital in Kerala at Kannur. All our units are working to their optimal capacity to meet the rush of patients across all geographies. We have been focusing on ensuring that our mission to provide affordable and accessible quality healthcare reaches everyone effectively. We are confident and on track to achieve our targets for FY 25.' Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences consolidated net profit rises 16.71% in the September 2024 quarter

Net profit of Krishna Institute of Medical Sciences rose 16.71% to Rs 107.40 crore in the quarter ended September 2024 as against Rs 92.02 crore during the previous quarter ended September 2023. Sales rose 19.13% to Rs 777.30 crore in the quarter ended September 2024 as against Rs 652.48 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales777.30652.48 19 OPM %28.0627.17 - PBDT203.20171.22 19 PBT162.20138.62 17 NP107.4092.02 17 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Spotlight
KIMS Hospitals expands into Kerala; plans to establish 3000 beds over next 5 years

The company intends to develop new medical facilities and acquire 3000 beds in the state over the next five years in Kerala. KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds. In a regulatory filing made post market hours today, the company stated that it has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway. Over the next two years, the group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode, each with 800-bed capacities. The group's expansion blueprint includes setting up a fully equipped oncology and transplant centre in Kannur, along with a 350-bed hospital in Thrissur dedicated to advanced transplant services. In future plans, KIMS intends to acquire hospitals in Calicut and Trivandrum. In the distant future, it plans to explore possibility of opening one hospital in all districts of Kerala. All our units will mostly be asset light model. Dr Bhaskar Rao, chairman and manging director, KIMS Hospitals said: 'Our sole aim is to bring accessible and affordable clinical healthcare services with world-class amenities to the people of Kerala and ensure that no patient in need is deprived of treatment due to financial constraints. Headquartered in Hyderabad, Krishna Institute of Medical Sciences Limited (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The hospital chain operator had reported 7.18% increase in consolidated net profit to Rs 86.6 crore in Q1 FY25 from Rs 80.8 crore posted in Q1 FY24. Revenue from operations rose by 13.6% year on year (YoY) to Rs 688.4 crore during the quarter ended June 2024. The scrip had gained 0.49% to end at Rs 559.30 on the BSE today. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
KIMS unveils plans for expansion in Kerala

Krishna Institute of Medical Sciences (KIMS) Hospitals has announced the expansion into Kerala, to develop new medical facilities and acquire 3000 beds in the state over the next five years. KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds. KIMS has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway. Over the next two years, the group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode, each with 800-bed capacities. The group's expansion blueprint includes setting up a fully equipped oncology and transplant centre in Kannur, along with a 350-bed hospital in Thrissur dedicated to advanced transplant services. In future plans, KIMS intends to acquire hospitals in Calicut and Trivandrum. In the distant future, it plans to explore possibility of opening one hospital in all districts of Kerala. All our units will mostly be asset light model. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Krishna Institute of Medical Sci. schedules board meeting

Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
KIMS signs MoU with Wipro GE Healthcare

Krishna Institute of Medical Sciences (KIMS) signed a Memorandum of Understanding (MoU) to procure medical technology and services of Upto Rs 700 crore with Wipro GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator. As part of this MoU, Wipro GE Healthcare will be an end-to-end medical technology partner for KIMS providing new products, replacements, and service to the existing and new branches of the hospital system over the next 3 years. The MoU covers full suite of medical technology products designed, developed and manufactured by Wipro GE Healthcare including PET CTs, SPEC CTs, Cath labs, MRIs, CT Scanners, ultrasounds, and critical care equipment, among others. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Krishna Institute of Medical Sciences fixes record date for stock split

Krishna Institute of Medical Sciences has fixed 13 September 2024 as record date for determining the eligibility of shareholders of the Company for sub-division/ split of 1 equity share having a face value of Rs.10 each, fully paid-up, be sub-divided into 5 equity shares having a face value of Rs.2 each, fully paid-up.Powered by Capital Market - Live

2 months agoCapital Market - Live
Spotlight
Volumes jump at Krishna Institute of Medical Sciences Ltd counter

Zomato Ltd, Praj Industries Ltd, Angel One Ltd, UTI Asset Management Company Ltd are among the other stocks to see a surge in volumes on BSE today, 20 August 2024.Krishna Institute of Medical Sciences Ltd witnessed volume of 7.81 lakh shares by 10:46 IST on BSE, a 147.38 times surge over two-week average daily volume of 5300 shares. The stock dropped 1.29% to Rs.2,346.85. Volumes stood at 11102 shares in the last session.Zomato Ltd notched up volume of 2028.12 lakh shares by 10:46 IST on BSE, a 57.93 fold spurt over two-week average daily volume of 35.01 lakh shares. The stock slipped 1.14% to Rs.259.30. Volumes stood at 57.54 lakh shares in the last session.Praj Industries Ltd clocked volume of 3.64 lakh shares by 10:46 IST on BSE, a 5.28 times surge over two-week average daily volume of 69004 shares. The stock gained 3.47% to Rs.779.20. Volumes stood at 77679 shares in the last session.Angel One Ltd registered volume of 2.74 lakh shares by 10:46 IST on BSE, a 4.05 fold spurt over two-week average daily volume of 67712 shares. The stock rose 8.43% to Rs.2,541.10. Volumes stood at 1.79 lakh shares in the last session.UTI Asset Management Company Ltd recorded volume of 30455 shares by 10:46 IST on BSE, a 3.77 times surge over two-week average daily volume of 8088 shares. The stock gained 4.80% to Rs.1,109.50. Volumes stood at 11057 shares in the last session.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
KIMS Hospitals' rises as Q1 PAT climbs 7% YoY; ARPOB at Rs 38,458

Revenue from operations rose by 13.6% year on year (YoY) to Rs 688.4 crore during the quarter ended June 2024. Profit before tax in first quarter of FY25 stood at Rs 127.1 crore, up by 7.17% from Rs 118.6 crore posted in corresponding quarter a year ago. Consolidated EBITDA grew by 14.9% YoY to Rs 184 crore and consolidated EBITDA margin rose by 30 basis points YoY to 26.6% in June 2024 quarter. Krishna Institute's average revenue per occupied bed (ARPOB) rose by 6.1% YoY to Rs 38,458. Average revenue per patient (ARPP) grew by 21.3% YoY to Rs 1,39,398. The company conducted 4.2 lakhs OPD consults in Q1 FY25, which increased by 10.2% on YoY basis. Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: 'FY25 has begun on a robust note. Most of our units have performed as per targets, especially the newer ones of Nagpur and Sunshine. Clinical additions to key departments over the last few quarters have helped us serve our patients better and add to our topline too. Nashik unit will be operational this quarter and we are excited by the clinical talent that has come on board. I am optimistic that we are on track to achieve our targets for FY25.' Headquartered in Hyderabad, Krishna Institute of Medical Sciences Limited (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences consolidated net profit rises 7.18% in the June 2024 quarter

Net profit of Krishna Institute of Medical Sciences rose 7.18% to Rs 86.60 crore in the quarter ended June 2024 as against Rs 80.80 crore during the previous quarter ended June 2023. Sales rose 13.60% to Rs 688.40 crore in the quarter ended June 2024 as against Rs 606.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales688.40606.00 14 OPM %26.0625.92 - PBDT166.10150.90 10 PBT127.10118.60 7 NP86.6080.80 7 Powered by Capital Market - Live

3 months agoCapital Market - Live